Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1984 1
1990 1
1991 1
1992 1
1994 5
1995 3
1996 4
1997 6
1998 10
1999 5
2000 3
2001 9
2002 5
2003 2
2004 3
2005 2
2006 7
2007 6
2008 3
2009 4
2010 6
2011 4
2012 6
2013 6
2014 12
2015 6
2016 2
2017 3
2018 4
2019 5
2020 3
2021 7
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G. Absolom K, et al. Among authors: hewison j. J Clin Oncol. 2021 Mar 1;39(7):734-747. doi: 10.1200/JCO.20.02015. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417506 Free article. Clinical Trial.
Reply to H. Shojima et al.
Absolom K, Warrington L, Hudson E, Hewison J, Holch P, Dawkins B, Hulme C, Brown J, Velikova G. Absolom K, et al. Among authors: hewison j. J Clin Oncol. 2021 Aug 10;39(23):2633-2634. doi: 10.1200/JCO.21.00684. Epub 2021 May 12. J Clin Oncol. 2021. PMID: 33979207 Free PMC article. No abstract available.
Screening for fragile X syndrome.
Murray J, Cuckle H, Taylor G, Hewison J. Murray J, et al. Among authors: hewison j. Health Technol Assess. 1997;1(4):i-iv, 1-71. Health Technol Assess. 1997. PMID: 9414543 Free article. Review.
Screening for cystic fibrosis.
Murray J, Cuckle H, Taylor G, Littlewood J, Hewison J. Murray J, et al. Among authors: hewison j. Health Technol Assess. 1999;3(8):i-iv, 1-104. doi: 10.2165/00115677-199803040-00001. Health Technol Assess. 1999. PMID: 10374080 Free article. Review. No abstract available.
Methodology over metrics: Response to Van Calster et al.
Bunce C, Hewison J, Teare MD, Al-Janabi H, Bonnett L, Hulme C, Kanaan M, Mitchell E, Peters T, Wason J, Williamson P. Bunce C, et al. Among authors: hewison j. J Clin Epidemiol. 2022 Mar;143:254. doi: 10.1016/j.jclinepi.2021.11.008. Epub 2021 Dec 3. J Clin Epidemiol. 2022. PMID: 34864202 No abstract available.
Ethical issues in the design and conduct of randomised controlled trials.
Edwards SJ, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J. Edwards SJ, et al. Among authors: hewison j. Health Technol Assess. 1998 Dec;2(15):i-vi, 1-132. Health Technol Assess. 1998. PMID: 10194615 Free article. Review. No abstract available.
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Brown JE, Royle KL, Gregory W, Ralph C, Maraveyas A, Din O, Eisen T, Nathan P, Powles T, Griffiths R, Jones R, Vasudev N, Wheater M, Hamid A, Waddell T, McMenemin R, Patel P, Larkin J, Faust G, Martin A, Swain J, Bestall J, McCabe C, Meads D, Goh V, Min Wah T, Brown J, Hewison J, Selby P, Collinson F; STAR Investigators. Brown JE, et al. Among authors: hewison j. Lancet Oncol. 2023 Mar;24(3):213-227. doi: 10.1016/S1470-2045(22)00793-8. Epub 2023 Feb 13. Lancet Oncol. 2023. PMID: 36796394 Free article. Clinical Trial.
151 results